Clinical Trial Update: PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Participants With Primary Sclerosing Cholangitis [Phase 2]

View source ↗

Summary

Phase 2 trial update on cenicriviroc in adults with primary sclerosing cholangitis reports preliminary efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• Cenicriviroc (cenicriviroc)

Snippet

Sponsor: Tobira Therapeutics, Inc. | Conditions: Primary Sclerosing Cholangitis | Phase 2 | Status: COMPLETED | Results posted: 2018-10-01